CalciMedica Inc. (“CalciMedica” or the “Company”) (Nasdaq: CALC), a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses, today announced that Rachel Leheny, Ph.D., Chief Executive Officer, will participate in a fireside chat at theH.C. Wainwright 4th Annual Kidney Virtual Conferenceon Monday, July 14, 2025, at 2:00 p.m. ET.
https://mma.prnewswire.com/media/685404/calcimedica_v3.jpg
A live webcast of the presentation can be accessed in the “IR Events and Presentations” section ofCalciMedica'sIR website. A replay of the webcast will be archived on the Company's website for 90 days.
About CalciMedicaCalciMedicais a clinical-stage biopharmaceutical company focused on developing novel CRAC channel inhibition therapies for inflammatory and immunologic diseases. CalciMedica'sproprietary technology targets the inhibition of CRAC channels to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory and immunologic diseases for which there are currently no approved therapies.CalciMedica'slead product candidateAuxora™ has demonstrated positive and consistent clinical results in multiple completed efficacy clinical trials and been well-tolerated in over 350 critically ill patients dosed. CalciMedica has announced data for a Phase 2b trial (called CARPO -NCT04681066) in patients with acute pancreatitis (AP) and accompanying systemic inflammatory response syndrome (SIRS) and for a Phase 2 trial (called CARDEA -NCT04345614) in patients with COVID pneumonia. The Company is currently conducting a Phase 2 trial (called KOURAGE -NCT06374797) in patients with acute kidney injury (AKI) with associated acute hypoxemic respiratory failure (AHRF). For more information, please visit www.calcimedica.com.
Contact InformationArgot Partnerscalcimedica@argotpartners.com(212) 600-1902
https://c212.net/c/img/favicon.png?sn=LA25124&sd=2025-07-08
View original content to download multimedia:https://www.prnewswire.com/news-releases/calcimedica-to-participate-in-the-hc-wainwright-4th-annual-kidney-virtual-conference-302499225.html
SOURCE CalciMedica, Inc.
https://rt.newswire.ca/rt.gif?NewsItemId=LA25124&Transmission_Id=202507080700PR_NEWS_USPR_____LA25124&DateId=20250708